SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-6
acquisitionAnnounced · Jan 19, 2026PharmaceuticalSource · CredibleArticle · Factual
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$10B
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Speculative
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Speculative. Sector: Pharmaceutical. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.
Sun Pharmaceutical Industries Ltd, India largest drugmaker by market capitalisation and revenue, is evaluating the acquisition of US-based Organon , a women healthcare specialist with a growing biosimilars portfolio, people familiar with the matter told The Economic Times
Deal timeline
Announced
Jan 19, 2026 · news18.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceutical with a reported deal value of $10B. Figures and status may change as sources update.
Sources: news18.com · Primary article · FireStrike proprietary index